Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways

Giovanna Damia, Simonetta Silvestri, Laura Carrassa, Laura Filiberti, Glynn T. Faircloth, Giordano Liberi, Marco Foiani, Maurizio D'Incalci

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

The cytotoxic activity of ecteinascidin 743 (ET-743), a natural product derived from the marine tunicate Ecteinascidia turbinata that exhibits potent anti-tumor activity in pre-clinical systems and promising activity in phase I and II clinical trials, was investigated in a number of cell systems with well-defined deficiencies in DNA-repair mechanisms. ET-743 binds to N2 of guanine in the minor groove, but its activity does not appear to be related to DNA-topoisomerase I poisoning as the drug is equally active in wild-type yeast and in yeast with a deletion in the DNA-topoisomerase I gene. Defects in the mismatch repair pathway, usually associated with increased resistance to methylating agents and cisplatin, did not affect the cytotoxic activity of ET-743. However, ET-743 did show decreased activity (from 2- to 8-fold) in nucleotide excision repair (NER)-deficient cell lines compared to NER-proficient cell lines, from either hamsters or humans. Restoration of NER function sensitized cells to ET-743 treatment. The DNA double-strand-break repair pathway was also investigated using human glioblastoma cell lines MO59K and MO59J, respectively, proficient and deficient in DNA-dependent protein kinase (DNA-PK). ET-743 was more effective in cells lacking DNA-PK; moreover, pre-treatment of HCT-116 colon carcinoma cells with wortmannin, a potent inhibitor of DNA-PK, sensitized cells to ET-743. An increase in ET-743 sensitivity was also observed in ataxia telangiectasia-mutated cells. Our data strongly suggest that ET-743 has a unique mechanism of interaction with DNA.

Original languageEnglish
Pages (from-to)583-588
Number of pages6
JournalInternational Journal of Cancer
Volume92
Issue number4
DOIs
Publication statusPublished - May 15 2001

Fingerprint

trabectedin
DNA Repair-Deficiency Disorders
DNA-Activated Protein Kinase
DNA Repair
Type I DNA Topoisomerase
Cell Line
Yeasts
Urochordata
Ataxia Telangiectasia
Phase II Clinical Trials
Clinical Trials, Phase I
DNA Mismatch Repair
Double-Stranded DNA Breaks

Keywords

  • ATM
  • DNA repair
  • DNA-protein kinase
  • ET-743
  • Marine compound
  • Nucleotide excision repair

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways. / Damia, Giovanna; Silvestri, Simonetta; Carrassa, Laura; Filiberti, Laura; Faircloth, Glynn T.; Liberi, Giordano; Foiani, Marco; D'Incalci, Maurizio.

In: International Journal of Cancer, Vol. 92, No. 4, 15.05.2001, p. 583-588.

Research output: Contribution to journalArticle

Damia, Giovanna ; Silvestri, Simonetta ; Carrassa, Laura ; Filiberti, Laura ; Faircloth, Glynn T. ; Liberi, Giordano ; Foiani, Marco ; D'Incalci, Maurizio. / Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways. In: International Journal of Cancer. 2001 ; Vol. 92, No. 4. pp. 583-588.
@article{ddd438fd55bc4edd93f0502fa49d7a44,
title = "Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways",
abstract = "The cytotoxic activity of ecteinascidin 743 (ET-743), a natural product derived from the marine tunicate Ecteinascidia turbinata that exhibits potent anti-tumor activity in pre-clinical systems and promising activity in phase I and II clinical trials, was investigated in a number of cell systems with well-defined deficiencies in DNA-repair mechanisms. ET-743 binds to N2 of guanine in the minor groove, but its activity does not appear to be related to DNA-topoisomerase I poisoning as the drug is equally active in wild-type yeast and in yeast with a deletion in the DNA-topoisomerase I gene. Defects in the mismatch repair pathway, usually associated with increased resistance to methylating agents and cisplatin, did not affect the cytotoxic activity of ET-743. However, ET-743 did show decreased activity (from 2- to 8-fold) in nucleotide excision repair (NER)-deficient cell lines compared to NER-proficient cell lines, from either hamsters or humans. Restoration of NER function sensitized cells to ET-743 treatment. The DNA double-strand-break repair pathway was also investigated using human glioblastoma cell lines MO59K and MO59J, respectively, proficient and deficient in DNA-dependent protein kinase (DNA-PK). ET-743 was more effective in cells lacking DNA-PK; moreover, pre-treatment of HCT-116 colon carcinoma cells with wortmannin, a potent inhibitor of DNA-PK, sensitized cells to ET-743. An increase in ET-743 sensitivity was also observed in ataxia telangiectasia-mutated cells. Our data strongly suggest that ET-743 has a unique mechanism of interaction with DNA.",
keywords = "ATM, DNA repair, DNA-protein kinase, ET-743, Marine compound, Nucleotide excision repair",
author = "Giovanna Damia and Simonetta Silvestri and Laura Carrassa and Laura Filiberti and Faircloth, {Glynn T.} and Giordano Liberi and Marco Foiani and Maurizio D'Incalci",
year = "2001",
month = "5",
day = "15",
doi = "10.1002/ijc.1221",
language = "English",
volume = "92",
pages = "583--588",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways

AU - Damia, Giovanna

AU - Silvestri, Simonetta

AU - Carrassa, Laura

AU - Filiberti, Laura

AU - Faircloth, Glynn T.

AU - Liberi, Giordano

AU - Foiani, Marco

AU - D'Incalci, Maurizio

PY - 2001/5/15

Y1 - 2001/5/15

N2 - The cytotoxic activity of ecteinascidin 743 (ET-743), a natural product derived from the marine tunicate Ecteinascidia turbinata that exhibits potent anti-tumor activity in pre-clinical systems and promising activity in phase I and II clinical trials, was investigated in a number of cell systems with well-defined deficiencies in DNA-repair mechanisms. ET-743 binds to N2 of guanine in the minor groove, but its activity does not appear to be related to DNA-topoisomerase I poisoning as the drug is equally active in wild-type yeast and in yeast with a deletion in the DNA-topoisomerase I gene. Defects in the mismatch repair pathway, usually associated with increased resistance to methylating agents and cisplatin, did not affect the cytotoxic activity of ET-743. However, ET-743 did show decreased activity (from 2- to 8-fold) in nucleotide excision repair (NER)-deficient cell lines compared to NER-proficient cell lines, from either hamsters or humans. Restoration of NER function sensitized cells to ET-743 treatment. The DNA double-strand-break repair pathway was also investigated using human glioblastoma cell lines MO59K and MO59J, respectively, proficient and deficient in DNA-dependent protein kinase (DNA-PK). ET-743 was more effective in cells lacking DNA-PK; moreover, pre-treatment of HCT-116 colon carcinoma cells with wortmannin, a potent inhibitor of DNA-PK, sensitized cells to ET-743. An increase in ET-743 sensitivity was also observed in ataxia telangiectasia-mutated cells. Our data strongly suggest that ET-743 has a unique mechanism of interaction with DNA.

AB - The cytotoxic activity of ecteinascidin 743 (ET-743), a natural product derived from the marine tunicate Ecteinascidia turbinata that exhibits potent anti-tumor activity in pre-clinical systems and promising activity in phase I and II clinical trials, was investigated in a number of cell systems with well-defined deficiencies in DNA-repair mechanisms. ET-743 binds to N2 of guanine in the minor groove, but its activity does not appear to be related to DNA-topoisomerase I poisoning as the drug is equally active in wild-type yeast and in yeast with a deletion in the DNA-topoisomerase I gene. Defects in the mismatch repair pathway, usually associated with increased resistance to methylating agents and cisplatin, did not affect the cytotoxic activity of ET-743. However, ET-743 did show decreased activity (from 2- to 8-fold) in nucleotide excision repair (NER)-deficient cell lines compared to NER-proficient cell lines, from either hamsters or humans. Restoration of NER function sensitized cells to ET-743 treatment. The DNA double-strand-break repair pathway was also investigated using human glioblastoma cell lines MO59K and MO59J, respectively, proficient and deficient in DNA-dependent protein kinase (DNA-PK). ET-743 was more effective in cells lacking DNA-PK; moreover, pre-treatment of HCT-116 colon carcinoma cells with wortmannin, a potent inhibitor of DNA-PK, sensitized cells to ET-743. An increase in ET-743 sensitivity was also observed in ataxia telangiectasia-mutated cells. Our data strongly suggest that ET-743 has a unique mechanism of interaction with DNA.

KW - ATM

KW - DNA repair

KW - DNA-protein kinase

KW - ET-743

KW - Marine compound

KW - Nucleotide excision repair

UR - http://www.scopus.com/inward/record.url?scp=0035874074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035874074&partnerID=8YFLogxK

U2 - 10.1002/ijc.1221

DO - 10.1002/ijc.1221

M3 - Article

VL - 92

SP - 583

EP - 588

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -